체외진단 품질관리 세계 시장은 2023년에 연평균 복합 성장률(CAGR) 8.30%로 13억 7,654만 달러에 이를 것으로 예측됩니다. 2030년에는 24억 1,276만 달러에 이르면서 경이적인 성장을 달성할 전망입니다.
FPNV 포지셔닝 매트릭스는 세계의 체외진단 품질관리 시장을 평가하는 데 필수적입니다. 비즈니스 전략과 제품 만족도의 주요 지표를 조사하여 공급업체에 대한 종합적인 평가를 제공하고 사용자가 특정 요구에 기반한 정보에 입각한 의사결정을 내릴 수 있도록 합니다. 이 고급 분석을 통해 공급업체는 성공 정도가 다른 4개의 사분면, 즉 Forefront (F), Pathfinder (P), Niche (N), Vital(V) 등 4개의 사분면으로 구성됩니다.
시장 점유율 분석은 특정 시장 영역에서 공급업체의 현재 상태를 파악할 수 있는 통찰력을 제공합니다. 전체 수익, 고객 기반 및 기타 주요 지표에 대한 벤더의 기여도를 비교함으로써 기업이 시장 점유율을 놓고 경쟁할 때 어떤 성과를 거두고 있는지, 어떤 상황에 직면해 있는지 더 깊이 이해할 수 있습니다. 또한, 이 분석은 조사된 기준 연도에 특정 부문의 경쟁 정도, 축적, 세분화 우위, 합병의 특징 등을 파악할 수 있도록 합니다.
이 보고서는 다음과 같은 사항에 대한 통찰력을 제공합니다.
1. 시장 침투도 : 주요 기업이 제공하는 시장에 관한 정보를 제공합니다.
2. 시장 발전 : 유리한 신흥 시장에 관한 상세 정보를 제공하며, 시장 성숙 부문 침투도를 분석합니다.
3. 시장 다양화 : 신제품 출시, 미개발 지역, 최근 개발, 투자에 관한 상세 정보를 제공합니다.
4. 시장 동향 : COVID-19, 러시아·우크라이나 분쟁, 고인플레이션의 누적 영향을 종합적에 이해할 수 있습니다.
5. 경쟁 평가와 정보 : 주요 기업의 시장 점유율, 전략, 제품, 인증, 규제 상황, 특허 상황, 제조능력을 종합적으로 평가합니다.
6. 제품 개발 및 혁신 : 향후 기술, 연구개발 활동, 획기적인 제품 개발에 관한 지적 통찰을 제공합니다.
이 보고서는 다음 질문에 대한 답변이 될 것입니다.
1. 체외진단 품질관리 세계 시장 규모 및 예측은?
2. 예측 기간 중 세계의 체외진단 품질관리 시장을 형성하는 COVID-19의 억제요인과 영향은?
3. 체외진단 품질관리 세계 시장에서 예측 기간중에 투자해야 할 제품/부문/용도/분야는?
4. 체외진단 품질관리 세계 시장 경쟁 전략은?
5. 체외진단 품질관리 세계 시장 기술 동향과 규제 프레임워크는?
6. 체외진단 품질관리 세계 시장 주요 벤더의 시장 점유율은?
7. 체외진단 품질관리 세계 시장에의 참여에는 어떠한 형태나 전략적인 동향이 적합하다고 생각하는가?
The Global In-Vitro Diagnostics Quality Control Market is forecasted to grow significantly, with a projected USD 1,376.54 million in 2023 at a CAGR of 8.30% and expected to reach a staggering USD 2,412.76 million by 2030.
The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global In-Vitro Diagnostics Quality Control Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.
Based on Offering, market is studied across Data Management Solutions, Quality Assurance Services, and Quality Control Products. The Quality Control Products is further studied across Serum/Plasma-Based Controls, Urine-Based Controls, and Whole-Blood-Based Controls. The Quality Control Products commanded largest market share of 41.46% in 2022, followed by Data Management Solutions.
Based on Distributor, market is studied across OEM and Third-Party Control Manufacturers. The Third-Party Control Manufacturers is further studied across Independent Manufacturer Controls and Instrument-Specific Controls. The Third-Party Control Manufacturers commanded largest market share of 64.76% in 2022, followed by OEM.
Based on Application, market is studied across Clinical Chemistry, Coagulation or Hemostasis, Hematology, Immunochemistry, Microbiology, and Molecular Diagnostics. The Immunochemistry commanded largest market share of 21.32% in 2022, followed by Clinical Chemistry.
Based on End-User, market is studied across Clinical Laboratories, Hospitals, and Research & Academic Institutes. The Clinical Laboratories commanded largest market share of 57.27% in 2022, followed by Hospitals.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 37.36% in 2022, followed by Americas.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
The FPNV Positioning Matrix is essential for assessing the Global In-Vitro Diagnostics Quality Control Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global In-Vitro Diagnostics Quality Control Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global In-Vitro Diagnostics Quality Control Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In-Vitro Diagnostics Quality Control Market?
4. What is the competitive strategic window for opportunities in the Global In-Vitro Diagnostics Quality Control Market?
5. What are the technology trends and regulatory frameworks in the Global In-Vitro Diagnostics Quality Control Market?
6. What is the market share of the leading vendors in the Global In-Vitro Diagnostics Quality Control Market?
7. What modes and strategic moves are considered suitable for entering the Global In-Vitro Diagnostics Quality Control Market?